Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 11/20 | 0.64 |
| ▸ | ROCK1 | Q13464 | 6/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.38 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19592079 | 0.89 | ROCK2 (0.63) | ROCK2ROCK1MAPK14JAK2EGFR | |
| SCHEMBL19591992 | 0.86 | ROCK2 (0.64) | ROCK2ROCK1EGFR | |
| SCHEMBL19592078 | 0.82 | ROCK2 (0.66) | ROCK2ROCK1 | |
| SCHEMBL23380752 | 0.82 | ROCK2 (0.66) | ROCK2ROCK1EGFR | |
| SCHEMBL19592018 | 0.80 | ROCK2 (0.63) | ROCK2ROCK1EGFRMAPK9MAPK10 | |
| SCHEMBL17070954 | 0.78 | ROCK2 (1.00) | ROCK2ROCK1 | |
| SCHEMBL18792356 | 0.71 | ROCK2 (0.66) | ROCK2ROCK1 | |
| SCHEMBL24943925 | 0.70 | ROCK2 (0.67) | ROCK2ROCK1 | |
| SCHEMBL24943344 | 0.68 | ROCK2 (0.68) | ROCK2ROCK1 | |
| SCHEMBL24943640 | 0.66 | ROCK2 (0.57) | ROCK2ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9815820-B2 | Rho kinase inhibitors | KADMON CORPORATION, LLC (US) | 2017-11-14 | — | — | US | disclosed |